Recent Company News

• 07:14 AM ET Jul 30, 2025
  

  Amarin Corp. reports Q2 EPS ($0.03) ($14.65, 0.00)

• 06:30 AM ET Jul 02, 2025
  

  HLS Therapeutics Announces Reimbursement for Vascepa® under Nova Scotia's Provincial Drug Plan

• 05:15 PM ET Jun 24, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 11:20 AM ET Jun 24, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (142 total)

• 09:16 AM ET Jun 24, 2025
  

  StreetAccount Summary - US Pre-market trading update

• 08:18 AM ET May 07, 2025
  

  StreetAccount Summary - US Pre-market trading

• 07:04 AM ET Jun 24, 2025
  

  Amarin announces exclusive license and supply agreement with Recordati to commercialize VAZKEPA (Icosapent Ethyl) in Europe ($12.60, 0.00)

• 07:15 AM ET May 07, 2025
  

  Amarin Corp. reports Q1 EPS ($0.04) vs FactSet ($0.77) [2 est, ($0.80)-(0.74)] ($10.19, 0.00)

• 01:27 PM ET Apr 11, 2025
  

  StreetAccount Activist Summary: Week of 7-Apr